Skip to Content

Tag: Financial Results


Suzanne Foster

Providers

AdaptHealth: Diabetes course correct shows ‘promising signs’ 

February 26, 2025Theresa Flaherty, Managing Editor

PLYMOUTH MEETING, Pa. – After consecutive declining quarters in Diabetes Health, AdaptHealth has remodeled its diabetes outreach program and integrated diabetes resupply into sleep resupply and adopted that segment's best practices, says CEO Suzanne Foster.  A diagnostic review highlighted several reasons for Diabetes Health’s underperformance, she told analysts on a recent call to discuss the company’s fourth quarter and full year 2024 financial results.  “Notwithstanding...

2024, AdaptHealth, Diabetes, Financial Results, fourth quarter, full year


Read Full Articlered right arrow icon

Suzanne Foster

Providers

AdaptHealth says it continues to make progress 

February 25, 2025HME News Staff

PLYMOUTH MEETING, Pa. - AdaptHealth has reported net revenue of $856.6 million for the fourth quarter of 2024, a 0.2% decrease compared to the same period in 2023, and $3.26 billion for the full year 2024, a 1.9% increase compared to 2023.  Net income was $50.3 million vs. a net loss of $254.5 million for the quarter and $90.4 million vs. a net loss of $678.9 million for the year.  “Over the course of the second half of 2024, we continued to make progress on our five areas of...

2024, AdaptHealth, Financial Results, fourth quarter, full year


Read Full Articlered right arrow icon

Also Noted

Henry Schein implements new org structure  

February 25, 2025HME News Staff

MELVILLE, N.Y. - Henry Schein has simplified its organizational structure and appointed Andrea Albertini and Tom Popeck to lead its three business groups as part of its 2025 to 2027 BOLD+1 Strategic Plan. Albertini will be responsible for Global Distribution and Value-Added Services Group and the Global Technology Group, and Popeck will be responsible for the Global Specialty Products Group. Albertini, who joined Henry Schein in 2013 and most recently served as president of the company’s International...

Financial Results, Henry Schein, Reorganization


Read Full Articlered right arrow icon

Greg Crawford

Providers

Quipt: ‘We’ve got a lot of levers that we’re pulling’ 

February 12, 2025Theresa Flaherty, Managing Editor

CINCINNATI – Quipt Home Medical is focusing on “steady progress” in the face of several headwinds, including an expected $3 million annual impact from the expiration of 75/25 blended Medicare reimbursement rates.  The company, which seeks to return to 8% to 10% organic growth rate in 2025, has also been impacted by the withdrawal of Medicare Advantage members due to a capitated agreement with other providers and a discontinued disposable supply contract.  “It’s...

Financial Results, First Quarter (Q1), fiscal year 2025, Quipt Home Medical


Read Full Articlered right arrow icon

Also Noted

Quipt: Results reflect ‘tangible progress’ 

February 11, 2025HME News Staff

CINCINNATI – Quipt Home Medical has reported revenue of $61.4 million for the first quarter of fiscal year 2025, a 2% increase compared to the same period last year. The company says its revenue was reduced by about $1.5 million for the three months ended Dec. 31, 2024, vs. the same period in 2023 due to:  Discontinued 75/25 blended Medicare reimbursement rates for certain areas  Withdrawal of Medicare Advantage members due to a capitated agreement with other providers  Discontinued...

Financial Results, First Quarter (Q1), fiscal year 2025, Quipt Home Medical


Read Full Articlered right arrow icon

Vendors

ResMed: ‘(We’re) well-positioned to capitalize on once-in-a-generation opportunities’ 

January 30, 2025HME News Staff

SAN DIEGO – ResMed reported second quarter 2025 revenue increased to $1.3 billion, a 10% increase on a constant currency basis year over year.   The company reported revenue in the U.S., Canada, and Latin America, excluding Residential Care Software, grew by 12%.  Other financial results for the quarter:  Gross margin improved 300 bps to 58.6%; non-GAAP gross margin improved 230 bps to 59.2%  Income from operations increased 52%; non-GAAP income...

CPAP Device, Financial Results, ResMed, Sleep Therapy


Read Full Articlered right arrow icon

Kevin Smith

Vendors

Inogen expects to exceed full-year guidance 

January 14, 2025HME News Staff

GOLETA, Calif. – Inogen estimates preliminary, unaudited total revenue for the full year 2024 to be in the range of $334.5 million to $335.5 million, reflecting YOY growth of 6% and exceeding the company’s previous full-year guidance of $329 million to $331 million.  The company says its performance was driven by strong, double-digit growth in business-to-business revenue, while it continues to work to stabilize direct-to-consumer revenue with initiatives to enhance overall profitability.  “2024...

Financial Results, Inogen


Read Full Articlered right arrow icon

Quipt reports 13% increase in setups 

Providers

Quipt reports 13% increase in setups 

December 17, 2024HME News Staff

CINCINNATI – Quipt Home Medical completed approximately 854,000 unique setups/deliveries in fiscal year 2024, an increase of 13%.  This includes approximately 480,000 respiratory resupply setups/deliveries for fiscal year 2024, compared to approximately 396,000 for fiscal year 2023, an increase of 21%.  “Our results for fiscal 2024 reflect the resilience of our business and the scalability of our operating model,” said Greg Crawford, chairman and CEO. “Despite...

Financial Results, Quipt Home Medical


Read Full Articlered right arrow icon

Lewis Gradon

Vendors

F&P on masks: ‘It looks like we’re taking market share’ 

December 4, 2024Liz Beaulieu, Editor

AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s Homecare product group helped to deliver record financial results for the first half of financial year 2025 on the back of strong performance from masks and accessories.  Revenue for the Homecare product group increased 14% and sales of masks and accessories increased 16% for the first half.  When asked by an analyst during a recent conference call whether F&P was taking share in the competitive mask category, CEO and...

CPAP Mask, Financial Results, Fisher & Paykel Healthcare


Read Full Articlered right arrow icon

Vendors

Inogen remains focused on growth, innovation, profitability 

November 7, 2024HME News Staff

GOLETA, Calif. - Inogen reported total revenue of $88.8 million for the third quarter of 2024, a 5.8% increase year over year, driven by higher demand and new customer gains across the domestic and international business-to-business channels.   Those gains were partially offset by lower direct-to-consumer sales and rental revenue.  “We continued to make significant progress on our strategic priorities in the third quarter,” said Kevin Smith, president and CEO. Our...

2024, Financial Results, Inogen, Third Quarter (Q3)


Read Full Articlered right arrow icon

|<<<12345>>>|